Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Biological Systems of Vitamin K: A Plasma Nutriproteomics Study of Subclinical Vitamin K Deficiency in 500 Nepalese Children.

Lee SE, Schulze KJ, Cole RN, Wu LS, Yager JD, Groopman J, Christian P, West KP Jr.

OMICS. 2016 Apr;20(4):214-23. doi: 10.1089/omi.2015.0178. Epub 2016 Feb 25.

2.

Vitamin K and hepatocellular carcinoma: The basic and clinic.

Jinghe X, Mizuta T, Ozaki I.

World J Clin Cases. 2015 Sep 16;3(9):757-64. doi: 10.12998/wjcc.v3.i9.757. Review.

3.

Inter and intra ethnic variation of vitamin K epoxide reductase complex and cytochrome P450 4F2 genetic polymorphisms and their prevalence in South Indian population.

Kumar DK, Shewade DG, Manjunath S, Ushakiran P, Reneega G, Adithan C.

Indian J Hum Genet. 2013 Jul;19(3):301-10. doi: 10.4103/0971-6866.120817.

4.

Vitamin K epoxide reductase contributes to protein disulfide formation and redox homeostasis within the endoplasmic reticulum.

Rutkevich LA, Williams DB.

Mol Biol Cell. 2012 Jun;23(11):2017-27. doi: 10.1091/mbc.E12-02-0102. Epub 2012 Apr 11.

5.

The pharmacogenetics of the response to warfarin in Chinese.

Lam MP, Cheung BM.

Br J Clin Pharmacol. 2012 Mar;73(3):340-7. doi: 10.1111/j.1365-2125.2011.04097.x. Review.

6.

Functional study of the vitamin K cycle in mammalian cells.

Tie JK, Jin DY, Straight DL, Stafford DW.

Blood. 2011 Mar 10;117(10):2967-74. doi: 10.1182/blood-2010-08-304303. Epub 2011 Jan 14.

7.

Hereditary combined deficiency of the vitamin K-dependent clotting factors.

Napolitano M, Mariani G, Lapecorella M.

Orphanet J Rare Dis. 2010 Jul 14;5:21. doi: 10.1186/1750-1172-5-21. Review.

8.

A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans.

Voora D, Koboldt DC, King CR, Lenzini PA, Eby CS, Porche-Sorbet R, Deych E, Crankshaw M, Milligan PE, McLeod HL, Patel SR, Cavallari LH, Ridker PM, Grice GR, Miller RD, Gage BF.

Clin Pharmacol Ther. 2010 Apr;87(4):445-51. doi: 10.1038/clpt.2009.291. Epub 2010 Mar 3.

9.

Association of sequence variations in vitamin K epoxide reductase and gamma-glutamyl carboxylase genes with biochemical measures of vitamin K status.

Crosier MD, Peter I, Booth SL, Bennett G, Dawson-Hughes B, Ordovas JM.

J Nutr Sci Vitaminol (Tokyo). 2009 Apr;55(2):112-9.

10.

Familial deficiency of vitamin K-dependent clotting factors.

Weston BW, Monahan PE.

Haemophilia. 2008 Nov;14(6):1209-13. doi: 10.1111/j.1365-2516.2008.01853.x.

11.

Vitamin K epoxide reductase complex subunit 1 (Vkorc1) haplotype diversity in mouse priority strains.

Song Y, Vera N, Kohn MH.

BMC Res Notes. 2008 Dec 1;1:125. doi: 10.1186/1756-0500-1-125.

12.
13.

Compound heterozygosity of novel missense mutations in the gamma-glutamyl-carboxylase gene causes hereditary combined vitamin K-dependent coagulation factor deficiency.

Darghouth D, Hallgren KW, Shtofman RL, Mrad A, Gharbi Y, Maherzi A, Kastally R, LeRicousse S, Berkner KL, Rosa JP.

Blood. 2006 Sep 15;108(6):1925-31. Epub 2006 May 23.

14.

The genetic basis of resistance to anticoagulants in rodents.

Pelz HJ, Rost S, Hünerberg M, Fregin A, Heiberg AC, Baert K, MacNicoll AD, Prescott CV, Walker AS, Oldenburg J, Müller CR.

Genetics. 2005 Aug;170(4):1839-47. Epub 2005 May 6.

15.

A new model for vitamin K-dependent carboxylation: the catalytic base that deprotonates vitamin K hydroquinone is not Cys but an activated amine.

Rishavy MA, Pudota BN, Hallgren KW, Qian W, Yakubenko AV, Song JH, Runge KW, Berkner KL.

Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13732-7. Epub 2004 Sep 13.

Supplemental Content

Support Center